Antithrombin I Activity

Marc Verstraete; Carl Vermylen

doi:10.1055/s-0038-1654419

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1959; 3(04): 640-653
DOI: 10.1055/s-0038-1654419

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Antithrombin I Activity

Its Interference with the Estimation of Antithrombin II Activity in Certain Thrombin Inhibitor Determinations

Authors

Marc Verstraete^*)

¹Laboratory of Physiopathology of the Department of Medicine (Prof. J. Vandenbroucke), University of Louvain, Belgium
Carl Vermylen

¹Laboratory of Physiopathology of the Department of Medicine (Prof. J. Vandenbroucke), University of Louvain, Belgium

References
1 Burstein M. Sur l’effet antithrombinique de l’héparine. Rôle de la concentration en héparine. C. R. Soc. Biol. (Paris) 1952; 146: 641
2 Burstein M, et Loeb J. Sur l’effet antithrombinique de l’héparine. Rôle du pH, de la concentration saline et des ions alcalino-terreux. C. R. Soc. Biol. (Paris) 1952; 146: 250
3 Nilsson I. M, Wenckert A. Demonstration of a heparin-like anticoagulant in normal blood. I. Human blood. Acta med. scand 1954; 150 suppl 297
4 Wenckert A, Nilsson I. M. Thromboplastin and Russell Viper venom. Scand. J. clin. Lab. Invest 1955; 7 suppl 15
5 Graham J. B, Barrow E. M. The pathogenesis of hemophilia. An experimental analysis of the anticephalin hypothesis in hemophilic dogs. J. exp. Med 1957; 106: 273
6 Jürgens J. Neue Bestimmungsmethoden und Bedeutung der Antithrombine für die Klinik. Klin. Wschr 1957; 35: 303
7 Schultze H. E, Schwick G. Laboratoriums-Blätter Behringwerke Nr. 1953: 2
8 Owren P.A. The coagulation of blood. Oslo: 1947
9 Kaulla K. N. Autoaktivierung und Autofibrinolyse. Eine einfache Schnellmethode zur Gewinnung hochaktiven, menschlichen Materials. Klin. Wschr 1957; 35: 667
10 Florkin M, en Massart M. Medische Biochemie. N. V. Standard-Boekhandel; Antwerpen: 1944
11 Philips G. E, Weiner M, Gilman L, Lenahan J. G. Non specific factors in blood coagulation. J. Lab. clin. Med 1955; 46: 644
12 Stormorken H, Newcomb T. F. The use of buffers in blood coagulation studies. Scand. J. clin. Lab. Invest 1956; 8: 237
13 Astrup T. Biochemistry of blood coagulation. Acta physiol. scand 1944; 7 suppl 21
14 Loeliger A, Hers J. F. Chronic Antithrombinaemia (Antithrombin V) with haemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulinaemia. Thromb. Diath. haem 1957; 1: 499
15 Vandenbroucke J, Verstraete M, Verwilghen R. L’afibrinogénémie congénitale. Présentation d’un nouveau cas et revue de la literature. Acta haemat. (Basel) 1954; 12: 87
16 Burstein M. Sur le pouvoir antithrombinique de l’héparine. Thrombose und Embolie. p. 303 Benno Schwabe; Basel: 1954
17 Astrup T, Darling Sv. Antithrombin and heparin. Acta physiol. scand 1943; 5: 13
18 Seegers W. H. Multiple protein interactions as exhibited by the blood-clotting mechanism. J. Phys. Coll. Chem 1947; 51: 198
19 Witte S, Dirnberger P. Antithrombin und Thrombininhibitor. Klin. Wschr 1953; 31: 598
20 Schmid J. Methode zur Bestimmung der Thrombininhibitoraktivität. Wien. Z. inn. Med 1951; 32: 108
21 Usteri C. Das Heparin-Komplement und seine physiologisch-klinische Bedeutung. Inaugural-Dissertation; Zürich: 1949